Three notes:
1. Per the agreement, OCM’s network of physicians will be able to use the ThermoGenesis PXP system to prepare a precise cell concentrate from autologous bone marrow in their office labs.
2. The PXP system is a lab equipment that automates the harvest of a precise volume of cell concentrate from bone marrow aspirate in a sterile process at the point of care. PXP can generate bone marrow monocular cells and platelets in less than 20 minutes.
3. Processing data is captured using ThermoGenesis’ proprietary DataTrak software to assist with optimal manufacturing monitoring and reporting information.
More articles on biologics:
CDC investigates contaminated stem cell products: 5 things to know
Global spine biologics market to hit $2.7B by 2024 — 18 key players
U of Missouri to release biojoint records amid allegations of false marketing: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
